Search results
Former Baller Matt Barnes Says We Were The ‘Guinea Pigs’ Of COVID Vaccines Amid Reported Side...
MadameNoire· 3 days agoFormer professional basketball player Matt Barnes gives his candid opinion about the FDA-approved ...
Allucent receives grant for decentralised Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoBy leveraging its expertise in DCTs, Allucent aims to facilitate broader participation and reduce...
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 1 day agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
Moderna says FDA delaying decision on RSV vaccine approval
Stars and Stripes· 7 days agoUS regulators’ decision on whether to approve Moderna Inc.’s vaccine for RSV has been delayed due to...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 4 hours agoUpdates from BMY: Bristol Myers BMY announced that the FDA had granted accelerated approval to the...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 6 days agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 6 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
Do We Have Enough Bird Flu Vaccines for a Potential Pandemic?
Scientific American· 5 hours agoThe Centers for Disease Control and Prevention and many experts maintain that the public health risk...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 3 days agoThe strong momentum is expected to drive sales further in 2024. Abrysvo is also approved for use in...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 6 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...